US Oncology Launches Oncology-Specific EHR to the Open Market

iKnowMed now available to community-based oncology practices

HOUSTON, June 10 /PRNewswire/ -- Today US Oncology, Inc., supporting the
nation's foremost cancer treatment and research network and working with
physicians, manufacturers and payers to advance cancer care in America,
announces the launch of iKnowMed(TM) to the open market. iKnowMed is an
oncology-specific electronic health record (EHR) system designed by
oncologists for oncologists.

Developed in 1996, US Oncology acquired iKnowMed in 2004. The comprehensive
collaboration between the oncology physicians since the acquisition has led to
a technology excellence that is completely focused on the needs of community
oncologists and their patients.

Today's iKnowMed goes beyond delivering standard EHR features by leveraging
technology that helps physicians focus on clinical excellence and cost
effectiveness in community cancer care. iKnowMed facilitates access to
powerful new solutions such as US Oncology's Innovent Oncology program, which
provides Level I evidence-based medicine pathways to help oncologists realize
the benefits of pay-for-performance. For practices participating in the US
Oncology Research network, iKnowMed can match patients to appropriate clinical
trials, increasing access to the latest treatment opportunities across the
nation.

Other features of iKnowMed include oncology-specific terminology, decision
support, outcomes reporting, imaging reports, comprehensive patient history,
comprehensive cancer regimen library, dictation and transcription, lab
results, detailed cancer diagnosis and staging content, and practice
efficiencies.

"As America's healthcare system moves toward a pay-for-performance
environment, in which higher-performing doctors receive preferred
compensation, it is essential that oncology practices accurately document and
report outcomes while achieving greater efficiency," says Cindy Chavez, vice
president of iKnowMed. "iKnowMed provides solutions that will help drive this
clinical excellence."

"We're excited about the opportunity to offer our electronic health record
system to the open market," says Bruce Broussard, president and CEO of US
Oncology. "With the recent signing of the American Recovery and Reinvestment
Act, which offers incentives to physicians for the meaningful use of health
technology, we are proud to offer oncologists an EHR solution that is
specifically designed to meet their needs."

iKnowMed provides physicians with online access to patient records 24 hours a
day, 7 days a week. This allows treatment decisions to be made from anywhere
at any time, without the need of a hardcopy patient record. Patient safety is
enhanced by eliminating handwritten notes and orders, minimizing
misinterpretations, and the system detects possible medication conflicts,
generating a safety alert to the attending oncologist and staff. The system
also helps practices stay current on billing as charge codes, billable units,
primary diagnosis codes and billable drug waste for each visit are calculated,
allowing staff to spend more time focusing on patient care.

Community oncologists across the nation are invited to attend a special
webinar focusing on the Medicare Health Information Technology (HIT) Stimulus
at 2 pm EDT, Friday, July 10. Sponsored by iKnowMed, this webinar will feature
a status report of standards for qualified EHRs and meaningful use
requirements -- as defined by the Office of the National Coordinator for
Health Information Technology (ONCHIT) at the Secretariat of Health & Human
Services (HHS) -- how standards should be set, and which standards should
apply to oncology-specific EHRs. To register for the webinar, visit
www.opspharmacist.com/HITStimulus. For more information on iKnowMed or other
US Oncology services, call (866) 216-5053 or visit www.usoncology.com.

About US Oncology
US Oncology, Inc., headquartered in the Houston area, works closely with
physicians, payers, biotechnology, pharmaceutical and medical equipment
manufacturers, to identify and deliver innovative services that enhance
patient access to advanced cancer care. US Oncology supports one of the
nation's foremost cancer treatment and research networks, accelerating the
availability and use of evidence-based medicine and shared best practices.

US Oncology uses its expertise to support every aspect of the cancer care
delivery system--from drug development to distribution and outcomes
measurement--enabling the company to help increase the efficiency and safety
of cancer care. According to the company's last quarterly earnings report, US
Oncology is affiliated with 1,227 physicians operating in 468 locations,
including 95 radiation oncology facilities in 39 states. For more information,
visit the company's Web site, www.usoncology.com.

SOURCE US Oncology, Inc.

Jennifer Horspool of US Oncology, Inc., +1-281-863-6739,
Jennifer.Horspool@usoncology.com